Spekman Marloes L C, Ramondt Steven, Sweegers Maike G
Donor Studies, Department of Donor Medicine Research, Sanquin Research, Amsterdam, The Netherlands.
Department of Sociology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Transfusion. 2021 Apr;61(4):1112-1121. doi: 10.1111/trf.16235. Epub 2020 Dec 28.
To prevent (negative consequences of) temporary deferral due to low hemoglobin, the Dutch national blood service Sanquin introduced a ferritin monitoring policy in 2017. Ferritin is measured after the donation (as opposed to before donation for hemoglobin), and low ferritin levels lead to deferral of 6 (ferritin 15-30 ng/mL) or 12 months (ferritin <15 ng/mL). We explored the consequences of this policy on donor behavior and availability.
We included all Dutch whole blood donors who made a donation (attempt) between 13 November and 31 December 2017. At that point, the ferritin monitoring policy was randomly implemented in 8 of 29 regional clusters of collection centers. We extracted information from Sanquin's donor database about donors' deferrals, subsequent donation attempts, and donation cessation (up to 31 December 2019). Donors deferred for low ferritin were compared to those deferred for low hemoglobin or other reasons, as well as to donors who were not deferred.
A total of 55 644 donors were included (11% deferred). For donor behavior, we found that donors deferred for low ferritin less often unsubscribed and switched to other donation types, yet also made fewer donations in the follow-up period. For availability, we found they were less often deferred, yet they were unavailable to donate for a longer period.
Results suggest that the implementation of a ferritin monitoring policy may lead to a decrease in donor availability and reduced donations. However, the policy is successful in retaining more donors and reducing low hemoglobin deferrals.
为防止因血红蛋白水平低导致临时延期(的负面后果),荷兰国家血液服务机构Sanquin于2017年推出了一项铁蛋白监测政策。铁蛋白在献血后进行检测(与献血前检测血红蛋白相反),铁蛋白水平低会导致延期6个月(铁蛋白15 - 30 ng/mL)或12个月(铁蛋白<15 ng/mL)。我们探讨了该政策对献血者行为和献血可得性的影响。
我们纳入了2017年11月13日至12月31日期间进行献血(尝试)的所有荷兰全血献血者。此时,在29个区域采血中心集群中的8个随机实施了铁蛋白监测政策。我们从Sanquin的献血者数据库中提取了有关献血者延期、后续献血尝试和停止献血(截至2019年12月31日)的信息。将因铁蛋白水平低而延期的献血者与因血红蛋白水平低或其他原因延期的献血者以及未延期的献血者进行比较。
共纳入55644名献血者(11%被延期)。对于献血者行为,我们发现因铁蛋白水平低而延期的献血者较少退订并转为其他献血类型,但在随访期间献血次数也较少。对于献血可得性,我们发现他们较少被延期,但他们无法献血的时间更长。
结果表明,实施铁蛋白监测政策可能会导致献血可得性下降和献血量减少。然而,该政策在留住更多献血者和减少因血红蛋白水平低导致的延期方面是成功的。